Sergio Ruiz‐Llorente

1.6k total citations
30 papers, 680 citations indexed

About

Sergio Ruiz‐Llorente is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Sergio Ruiz‐Llorente has authored 30 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 11 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Sergio Ruiz‐Llorente's work include Cancer, Hypoxia, and Metabolism (7 papers), Adrenal and Paraganglionic Tumors (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Sergio Ruiz‐Llorente is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Adrenal and Paraganglionic Tumors (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Sergio Ruiz‐Llorente collaborates with scholars based in Spain, United States and United Kingdom. Sergio Ruiz‐Llorente's co-authors include Mercedes Robledo, Javier Benı́tez, Arancha Cebrián, Verónica García-Carpizo, Jacinto Sarmentero, María J. Barrero, David G. Pisano, Alberto Cascón, Marina Pollán and Cristina Montero‐Conde and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Sergio Ruiz‐Llorente

28 papers receiving 662 citations

Peers

Countries citing papers authored by Sergio Ruiz‐Llorente

Since Specialization

Citations

This map shows the geographic impact of Sergio Ruiz‐Llorente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Ruiz‐Llorente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Ruiz‐Llorente more than expected).

Fields of papers citing papers by Sergio Ruiz‐Llorente

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Ruiz‐Llorente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Ruiz‐Llorente. The network helps show where Sergio Ruiz‐Llorente may publish in the future.

Co-authorship network of co-authors of Sergio Ruiz‐Llorente

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Ruiz‐Llorente. A scholar is included among the top collaborators of Sergio Ruiz‐Llorente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Ruiz‐Llorente. Sergio Ruiz‐Llorente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial 2025 ·Clinical Cancer Research ·Juan Francisco Rodríguez-Moreno, Guillermo de Velasco, Carlos Álvarez-Fernández, (unknown), Ricardo Fernández, (unknown), Juan Antonio Virizuela, Pablo Gajate, Albert Font, Núria Laínez, (unknown), Osvaldo Graña‐Castro, (unknown), Rodrigo Madurga, Cristina Rodríguez‐Antona, Pedro Berraondo, Sergio Ruiz‐Llorente, Jesús García-Donás	0
2	Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer 2024 ·Journal of Clinical Investigation ·(unknown), (unknown), (unknown), Paloma Navarro, (unknown), (unknown), (unknown), (unknown), Héctor Peinado, Elena Izquierdo, (unknown), (unknown), (unknown), Rodrigo Madurga, (unknown), Sergio Ruiz‐Llorente, Jesús García-Donás	15
3	Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study 2024 ·Clinical & Translational Oncology ·Paloma Navarro, Carmen Beato, Juan Francisco Rodríguez-Moreno, Sergio Ruiz‐Llorente, Xabier Mielgo-Rubio, Estela Pineda, M Navarro, G. Bruixola, (unknown), A. Viúdez, José Luís Fuster, (unknown), (unknown), Carmen Balañá, Carlos Mendez‐Dorantes, (unknown), Sonia Del Barco Berrón, (unknown), Alberto Carmona‐Bayonas, Jesús García-Donás	0
4	MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer 2022 ·Clinical & Translational Oncology ·(unknown), Sergio Ruiz‐Llorente, Juan Francisco Rodríguez-Moreno, (unknown), Juan Carlos Torrego Seijo, (unknown), Paloma Navarro, (unknown), (unknown), (unknown), Jesús García-Donás	15
5	Multivariate feature selection and autoencoder embeddings of ovarian cancer clinical and genetic data 2022 ·Expert Systems with Applications ·(unknown), Sergio Ruiz‐Llorente, Sergio Muñoz-Romero, (unknown), (unknown), Jesús García-Donás, José Luis Rojo‐Álvarez	8
6	Text Analytics and Mixed Feature Extraction in Ovarian Cancer Clinical and Genetic Data 2021 ·IEEE Access ·(unknown), Sergio Ruiz‐Llorente, Sergio Muñoz-Romero, (unknown), (unknown), Jesús García-Donás, José Luis Rojo‐Álvarez	5
7	CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines 2019 ·Molecular Cancer Research ·Verónica García-Carpizo, Sergio Ruiz‐Llorente, Jacinto Sarmentero, Ana González‐Corpas, María J. Barrero	28
8	CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation 2018 ·Epigenetics & Chromatin ·Verónica García-Carpizo, Sergio Ruiz‐Llorente, Jacinto Sarmentero, Osvaldo Graña‐Castro, David G. Pisano, María J. Barrero	44
9	NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation 2016 ·Scientific Reports ·Verónica García-Carpizo, Jacinto Sarmentero, Bomie Han, Osvaldo Graña‐Castro, Sergio Ruiz‐Llorente, David G. Pisano, Manuel Serrano, Harold B. Brooks, Robert M. Campbell, María J. Barrero	42
10	An Epistatic Interaction between the PAX8 and STK17B Genes in Papillary Thyroid Cancer Susceptibility 2013 ·PLoS ONE ·Iñigo Landa, César Boullosa, Lucía Inglada‐Pérez, Ana Sastre-Perona, Susana Pastor, Antonia Velázquez, Veronika Mančíková, Sergio Ruiz‐Llorente, Francesca Schiavi, Ricard Marcos, Núria Malats, Giuseppe Opocher, Ramón Díaz‐Uriarte, Pilar Santisteban, Alfonso Valencia, Mercedes Robledo	7
11	Abstract 3402: Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF mutant thyroid carcinomas. 2013 ·Cancer Research ·Cristina Montero‐Conde, Sergio Ruiz‐Llorente, José Miguel Domínguez, Jeffrey A. Knauf, Agnès Viale, Eric J. Sherman, Mabel Ryder, Ronald Ghossein, Neal Rosen, James A. Fagin	2
12	Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line 2012 ·Nuclear Medicine and Biology ·(unknown), Tae Yong Kim, Sergio Ruiz‐Llorente, Min Ji Jeon, Ji Min Han, Won Gu Kim, Young Kee Shong, Won Bae Kim	12
13	Genome-wide analysis of Pax8 binding provides new insights into thyroid functions 2012 ·BMC Genomics ·Sergio Ruiz‐Llorente, Enrique Carrillo de Santa Pau, Ana Sastre-Perona, Cristina Montero‐Conde, Gonzalo Goméz-López, James A. Fagin, Alfonso Valencia, David G. Pisano, Pilar Santisteban	36
14	Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients 2007 ·Human Mutation ·Alberto Cascón, (unknown), Cristina Montero‐Conde, Cristina Rodríguez‐Antona, Sergio Ruiz‐Llorente, Ana Osório, Fátima Mercadillo, Rocío Letón, José M. de Campos, José Miguel García‐Sagredo, Javier Benı́tez, Marcos Malumbres, Mercedes Robledo	30
15	Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: A possible hot spot? 2005 ·Genes Chromosomes and Cancer ·Alberto Cascón, Cristina Montero‐Conde, Sergio Ruiz‐Llorente, Fátima Mercadillo, Rocío Letón, Cristina Rodríguez‐Antona, Beatriz Martı́nez-Delgado, (unknown), Alberto B. Díez, Adela Rovira, José Ángel Díaz, Mercedes Robledo	44
16	Genetic characterization and structural analysis of VHL Spanish families to define genotype–phenotype correlations 2004 ·Human Mutation ·Sergio Ruiz‐Llorente, Jerónimo Bravo, Arancha Cebrián, Alberto Cascón, Marina Pollán, Dolores Tellerı́a, Rocío Letón, Miguel Urioste, Raquel Rodríguez‐López, José M. de Campos, María José Muñoz, (unknown), Javier Benı́tez, Mercedes Robledo	24
17	PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level 2004 ·Nucleic Acids Research ·Lucía Conde, Juan M. Vaquerizas, (unknown), Fátima Al‐Shahrour, Sergio Ruiz‐Llorente, Mercedes Robledo, Joaquı́n Dopazo	79
18	A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma 2004 ·Genes Chromosomes and Cancer ·Alberto Cascón, Sergio Ruiz‐Llorente, Sandra Rodríguez, Emiliano Honrado, Ángel Martínez‐Ramírez, Rocío Letón, Cristina Montero‐Conde, Javier Benı́tez, Joaquı́n Dopazo, Juan C. Cigudosa, Mercedes Robledo	25
19	Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1) 2003 ·Human Genetics ·Bárbara Meléndez, Sandra Rodríguez, Beatriz Martı́nez-Delgado, (unknown), Mercedes Robledo, Ángel Martínez‐Ramírez, Sergio Ruiz‐Llorente, Miguel Urioste, Juan C. Cigudosa, Javier Benı́tez	14
20	Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma 2002 ·European Journal of Human Genetics ·Alberto Cascón, Sergio Ruiz‐Llorente, Arancha Cebrián, Dolores Tellerı́a, (unknown), Juan J. Díez, (unknown), (unknown), Javier Benı́tez, Mercedes Robledo	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact